HELIXCARE: A DNA-based Health Prediction and Drug Recommendation System

Authors

  • Cevin R Christo Department of Data Science and Business Systems, SRM Institute of Science and Technology, Kattankulathur, Chennai, India Author
  • Divyanshi Kochar Department of Data Science and Business Systems, SRM Institute of Science and Technology, Kattankulathur, Chennai, India Author
  • Apurv Bhardwaj Department of Data Science and Business Systems, SRM Institute of Science and Technology, Kattankulathur, Chennai, India Author

DOI:

https://doi.org/10.63503/acset.130

Keywords:

Precision Medicine, Pharmacogenomics, Single Nucleotide Polymorphism, Random Forest, Ensemble Learning, Drug-Gene Interaction, PharmGKB, Clinical Decision Support, Health Informatics, SDG 3, SDG 9

Abstract

Modern medicine often assumes uniform drug responses, yet genetic variations, especially Single Nucleotide Polymorphisms (SNPs), significantly influence treatment outcomes, leading to adverse reactions and inefficiencies. HelixCare is a web-based precision medicine platform designed to bridge this gap by integrating genomic, clinical and lifestyle data to enable personalised healthcare decisions. The system accepts SNP data (VCF/CSV) along with attributes such as age, BMI, and lifestyle factors, and generates disease risk predictions using an ensemble Random Forest model trained on 106 features. It achieves 87.3% accuracy and an AUC of 0.923, outperforming traditional models including Logistic Regression, SVM, MLP and XGBoost (p < 0.001). HelixCare also incorporates a pharmacogenomic recommendation engine that leverages high-evidence drug–gene interactions from PharmGKB, ClinVar and dbSNP to guide safer medication choices, including dose adjustments and drug avoidance. Built on a React-based frontend and a Flask backend, the system ensures efficient, low-latency performance and secure data handling via AES-256 encryption and role-based access control. By enabling accessible, data-driven insights, HelixCare promotes a shift toward proactive, personalised healthcare aligned with global health innovation goals. 

References

[1] H. Wang, Y. Liu, and M. Zhang, "Polygenic risk scores for personalised disease prediction: a systematic review," Nature Reviews Genetics, vol. 24, no. 8, pp. 521 to 539, 2023.

[2] M. Whirl-Carrillo et al., "An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine," Clinical Pharmacology and Therapeutics, vol. 110, no. 3, pp. 563 to 572, 2021.

[3] L. Breiman, "Random forests," Machine Learning, vol. 45, no. 1, pp. 5 to 32, 2001.

[4] T. Chen and C. Guestrin, "XGBoost: a scalable tree boosting system," in Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, 2016, pp. 785 to 794.

[5] D. R. Crosslin et al., "Genetic variation associated with cardiovascular risk in multi-ethnic cohorts," American Journal of Human Genetics, vol. 105, no. 1, pp. 112 to 125, 2019.

[6] J. P. A. Ioannidis, "Why most discovered true associations are inflated," Epidemiology, vol. 19, no. 5, pp. 640 to 648, 2008.

[7] S. M. Lundberg and S. I. Lee, "A unified approach to interpreting model predictions," in Advances in Neural Information Processing Systems, vol. 30, 2017, pp. 4765 to 4774.

[8] M. J. Landrum et al., "ClinVar: improving access to variant interpretations and supporting evidence," Nucleic Acids Research, vol. 46, no. D1, pp. D1062 to D1067, 2018.

[9] S. T. Sherry et al., "dbSNP: the NCBI database of genetic variation," Nucleic Acids Research, vol. 29, no. 1, pp. 308 to 311, 2001.

[10] D. Roden et al., "Pharmacogenomics: the genetics of variable drug responses," Circulation, vol. 123, no. 15, pp. 1661 to 1670, 2011.

[11] M. Pirmohamed, "Pharmacogenomics: current status and future perspectives," Nature Reviews Genetics, vol. 24, no. 6, pp. 350 to 362, 2023.

[12] World Health Organization, "Genomics and world health: report of the advisory committee on health research," WHO Press, Geneva, 2022.

[13] P. Danecek et al., "The variant call format and VCFtools," Bioinformatics, vol. 27, no. 15, pp. 2156 to 2158, 2011.

[14] F. Pedregosa et al., "Scikit-learn: machine learning in Python," Journal of Machine Learning Research, vol. 12, pp. 2825 to 2830, 2011.

[15] A. Grinberg, Flask Web Development: Developing Web Applications with Python, 2nd ed. Sebastopol, CA: O'Reilly Media, 2018.

[16] React Documentation Team, "React 18 official documentation," Meta Open Source, 2023. [Online]. Available: https://react.dev

[17] United Nations, "Sustainable development goals: goal 3 good health and well-being," UN Department of Economic and Social Affairs, 2015. [Online]. Available: https://sdgs.un.org/goals/goal3

[18] United Nations, "Sustainable development goals: goal 9 industry, innovation and infrastructure," UN Department of Economic and Social Affairs, 2015. [Online]. Available: https://sdgs.un.org/goals/goal9

[19] Office for Civil Rights, "HIPAA security rule technical safeguards," U.S. Department of Health and Human Services, 2013.

[20] European Parliament, "General Data Protection Regulation (GDPR), Regulation (EU) 2016/679," Official Journal of the European Union, 2016.

Downloads

Published

2026-09-15

Conference Proceedings Volume

Section

Articles

How to Cite

Cevin R Christo, Divyanshi Kochar, & Apurv Bhardwaj. (2026). HELIXCARE: A DNA-based Health Prediction and Drug Recommendation System . Adroid Conference Series: Engineering and Technology, 2(3), 204-228. https://doi.org/10.63503/acset.130